Europe - Euronext Paris - EPA:BN - FR0000120644 - Common Stock
The current stock price of BN.PA is 76.88 EUR. In the past month the price decreased by -0.8%. In the past year, price increased by 18.68%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BSN.DE | DANONE | 20.44 | 52.10B | ||
| JDEP.AS | JDE PEET'S NV | 25.6 | 15.49B | ||
| KRZ.I | KERRY GROUP PLC-A | 15.88 | 12.38B | ||
| LOTB.BR | LOTUS BAKERIES | 39.46 | 6.36B | ||
| GL9.I | GLANBIA PLC | 12.5 | 3.50B | ||
| LOUP.PA | L.D.C. SA | 12.5 | 3.10B | ||
| SZU.DE | SUEDZUCKER AG | N/A | 1.83B | ||
| NWL.MI | NEWPRINCES SPA | 2.59 | 869.13M | ||
| SAVE.PA | SAVENCIA SA | 8.7 | 824.96M | ||
| FLOB.BR | FLORIDIENNE | 82.05 | 640.00M | ||
| BON.PA | BONDUELLE SCA | N/A | 332.83M | ||
| WHATS.BR | WHAT'S COOKING | 6.6 | 204.60M |
Danone SA engages in the food processing industry. The company is headquartered in Paris, Ile-De-France and currently employs 90,000 full-time employees. The company operates through four segments: Essential Dairy and Plant-Based Products (EDP), Waters and Specialized Nutrition, including Early Life Nutrition and Medical Nutrition. EDP produces and distributes fresh fermented dairy products and other dairy specialties, plant-based products and beverages, coffee creamers and organic products; Waters sells bottled water and water sold in small and large containers; Early Life Nutrition offers baby formula (infant milk formula, follow-on milk, growing up milks), milk and fruit-based desserts, cereals, jars of baby food and ready-made baby food; Advanced Medical Nutrition offers adult or pediatric clinical nutrition products to be taken orally or through a tube in the event of malnutrition related to illness or other causes. The Company’s brands portfolio includes Activia, Actimel, Alpro, Danette, Danonino, Danio, evian, Volvic, Nutrilon/Aptamil, Nutricia, and others.
DANONE
17, boulevard Haussmann
Paris ILE-DE-FRANCE FR
Employees: 89528
Phone: 33144352020
Danone SA engages in the food processing industry. The company is headquartered in Paris, Ile-De-France and currently employs 90,000 full-time employees. The company operates through four segments: Essential Dairy and Plant-Based Products (EDP), Waters and Specialized Nutrition, including Early Life Nutrition and Medical Nutrition. EDP produces and distributes fresh fermented dairy products and other dairy specialties, plant-based products and beverages, coffee creamers and organic products; Waters sells bottled water and water sold in small and large containers; Early Life Nutrition offers baby formula (infant milk formula, follow-on milk, growing up milks), milk and fruit-based desserts, cereals, jars of baby food and ready-made baby food; Advanced Medical Nutrition offers adult or pediatric clinical nutrition products to be taken orally or through a tube in the event of malnutrition related to illness or other causes. The Company’s brands portfolio includes Activia, Actimel, Alpro, Danette, Danonino, Danio, evian, Volvic, Nutrilon/Aptamil, Nutricia, and others.
The current stock price of BN.PA is 76.88 EUR. The price increased by 0.52% in the last trading session.
DANONE (BN.PA) has a dividend yield of 2.75%. The yearly dividend amount is currently 2.1.
BN.PA has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
DANONE (BN.PA) currently has 89528 employees.
DANONE (BN.PA) has a market capitalization of 52.39B EUR. This makes BN.PA a Large Cap stock.
ChartMill assigns a technical rating of 7 / 10 to BN.PA. When comparing the yearly performance of all stocks, BN.PA is one of the better performing stocks in the market, outperforming 76.08% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to BN.PA. While BN.PA belongs to the best of the industry regarding profitability, there are concerns on its financial health.
Over the last trailing twelve months BN.PA reported a non-GAAP Earnings per Share(EPS) of 3.74. The EPS increased by 4.47% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.72% | ||
| ROA | 4.2% | ||
| ROE | 11.59% | ||
| Debt/Equity | 0.83 |
31 analysts have analysed BN.PA and the average price target is 80.89 EUR. This implies a price increase of 5.22% is expected in the next year compared to the current price of 76.88.
For the next year, analysts expect an EPS growth of 7.99% and a revenue growth 0.7% for BN.PA